Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Passage Of Defibrillator Bill, Device Studies Could Fuel Debate For OTC Status

This article was originally published in The Gray Sheet

Executive Summary

Congressional passage of the Cardiac Arrest Survival Act (HR 2498), supported by favorable results of an ongoing NIH sponsored study evaluating public access to automated external defibrillators (AEDs), could pave the way for the eventual over-the-counter availability of the devices.

You may also be interested in...



OSHA Monitoring NIH External Defibrillator Study, Circulates “Fact Card”

The Occupational Safety & Health Administration will weigh results from a NIH study in evaluating the cost-effectiveness of options such as the American Heart Association's proposed public access defibrillation (PAD) program

OSHA Monitoring NIH External Defibrillator Study, Circulates “Fact Card”

The Occupational Safety & Health Administration will weigh results from a NIH study in evaluating the cost-effectiveness of options such as the American Heart Association's proposed public access defibrillation (PAD) program

Cardiac Science Gains Public AED Platform With Survivalink's FirstSave

Cardiac Science Inc. will integrate its RHYTHMx ECD tachyarrhythmia detection and defibrillation software into Survivalink's FirstSave automatic external defibrillator (AED) product line following its acquisition of the Minneapolis-based firm, announced Feb. 14.

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel